SCCM Resource Library-Assessment of Readmission Risk Factors After Index Hospital Discharge for COVID-19 Patients

Assessment of Readmission Risk Factors After Index Hospital Discharge for COVID-19 Patients

Video Transcription

Video Summary

Dr. Vikas Bansal, a research associate at Mayo Clinic Rochester, conducted a study on readmission risk factors for COVID-19 patients after hospital discharge. The study analyzed data from the International SCCM Discovery Virus COVID-19 Registry, which included over 85,000 adult patients from 28 countries. The study found that readmitted patients were more likely to be older and have comorbidities such as hypertension, obesity, diabetes, and dyslipidemia. They were also more likely to have shorter hospital stays, lower ICU admission rates, and fewer pulmonary complications. However, the study had limitations, including variations in discharge criteria and a lack of data on long COVID and patients transferred to other healthcare facilities.

Asset Subtitle

Infection, Quality and Patient Safety, 2023

Asset Caption

Type: star research | Star Research Presentations: Infectious Disease (SessionID 30012)

Meta Tag

Content Type Presentation

Knowledge Area Infection

Knowledge Area Quality and Patient Safety

Membership Level Professional

Membership Level Select

Tag COVID-19

Tag Evidence Based Medicine

Year 2023

Keywords

readmission risk factors

COVID-19 patients

comorbidities

hospital stays

ICU admission rates

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.